Abstract
Ovarian cancer has the highest mortality of all gynecologic cancers. Patients at high risk need technologies available that can detect early malignant changes. Optical techniques, possibly in conjunction with proteomic analyses of blood serum, will play an important role in the screening of high risk patients as well as diagnostic confirmation during surgical interventions.
© 2003 Optical Society of America
PDF ArticleMore Like This
Urs Utzinger, Molly Brewer, Ned Kirkpatrick, and Rebekah Drezek
CThI1 Conference on Lasers and Electro-Optics (CLEO:S&I) 2004
Jennifer K. Barton, Jen W. Koevary, Photini Faith Rice, and Travis W. Sawyer
OT2D.2 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2019
Utzinger Urs, Kirkpatrick Nathaniel, Brands William, Brewer Molly, and Drezek Rebekah
FTuBB2 Frontiers in Optics (FiO) 2005